Your browser doesn't support javascript.
loading
Performance assessment and validation of a plaque reduction neutralization test (PRNT) in support to yellow fever diagnostic and vaccine clinical trials.
Dia, Moussa; Bob, Ndeye Sakha; Talla, Cheikh; Dupressoir, Anne; Escadafal, Camille; Thiam, Mareme Seye; Diallo, Amadou; Ndiaye, Oumar; Heraud, Jean Michel; Faye, Oumar; Sall, Amadou Alpha; Faye, Ousmane; Fall, Gamou.
Afiliación
  • Dia M; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Bob NS; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Talla C; Epidemiology, Clinical Research and Data Science Department, Institute Pasteur de Dakar, Dakar, Senegal.
  • Dupressoir A; Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, CNRS UMR 9196, Villejuif, France.
  • Escadafal C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Thiam MS; Epidemiology, Clinical Research and Data Science Department, Institute Pasteur de Dakar, Dakar, Senegal.
  • Diallo A; Epidemiology, Clinical Research and Data Science Department, Institute Pasteur de Dakar, Dakar, Senegal.
  • Ndiaye O; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Heraud JM; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Faye O; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Sall AA; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Faye O; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
  • Fall G; Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
J Med Virol ; 95(4): e28700, 2023 04.
Article en En | MEDLINE | ID: mdl-36951314

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fiebre Amarilla / Vacunas / Vacuna contra la Fiebre Amarilla Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Senegal

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fiebre Amarilla / Vacunas / Vacuna contra la Fiebre Amarilla Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Senegal